Latest from sinopharm

Omicron routs J&J vaccine in lab study, may evade Sinovac and BioNTech too

A study, conducted by scientists at the microbiology department of the University of Hong Kong, showed that insufficient antibodies were generated by the Sinovac and BioNTech products to fend off Omicron.

Omicron is more infectious than Delta, but it remains unclear whether it is also more dangerous. (File Photo)
Published on Dec 15, 2021 01:26 PM IST
Written by Joydeep Bose | Edited by Avik Roy, Hindustan Times, New Delhi

China's Covid-19 vaccine Sinopharm less effective in protecting the elderly

This is not the first time questions have been raised about the efficacy of the vaccine, which was given a greenlight by the World Health Organization in May and is being used in more than 50 countries

The vaccine is one of two similar shots developed by Sinopharm(REUTERS)
Published on Jul 23, 2021 03:49 PM IST
AP | | Posted by Shanza Khan, Budapest, Hungary

Hungary concerned over efficacy of China's Sinopharm vaccine

Budapest residents who were fully vaccinated got free test inspecting the development of antibodies to defend Covid-19, out of which 60 residents who received China's Sinopharm vaccine hadn't developed antibodies.

Sinopharm is developed by the Beijing Institute of Biological Products, a state-owned subsidiary conglomerate.(REUTERS)
Published on Jul 09, 2021 09:16 PM IST
AP | | Posted by Shanza Khan, Budapest, Hungary

China fumes after Nepal's media exposes price of procuring Sinopharm jabs

Nepal had to sign a non-disclosure agreement with China over the procurement of Sinopharm Covid-19 vaccines. However, a report by a regional publication revealed the price of procurement, citing confirmation from two ministers and two government secretaries, much to Beijing's displeasure

Chinese president Xi Jinping. (File Photo)
Published on Jun 20, 2021 10:04 AM IST
By | Edited by Joydeep Bose

Sinopharm can provide over billion Covid-19 vaccine doses to world: Chairman

That level of supply capability assumes vaccination demand in China is being met, China National Pharmaceutical Group's chairman Liu Jingzhen said.

Two vaccines from Sinopharm are being used in China, one of which has gained emergency use approval from the World Health Organization, a prerequisite for a vaccine to be included in the COVAX initiative.(AFP)
Published on Jun 02, 2021 09:29 PM IST
Reuters | , Beijing
Story Saved
Saved Articles
My Reads
My Offers
Sign out
New Delhi 0C
Friday, March 24, 2023
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals